Summary
Updated Aug 31, 2026
James Joseph Martin is Co-CEO and CFO of Cocrystal Pharma, Inc. (COCP). 3 SEC Form 4 filings on record going back to 2024, most recently on 13 January 2026.
Recent Transactions
2Every recent SEC Form 4 transaction James Joseph Martin has reported, most recent first.
Trading Pattern
InsiderAlpha's records for James Joseph Martin go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies James Joseph Martin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Phillip Md Et Al Frost - $300K of COCP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James Joseph Martin?
James Joseph Martin is a corporate insider, tracked as Co-CEO and CFO of Cocrystal Pharma, Inc. (COCP). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James Joseph Martin last file a Form 4?
The most recent primary Form 4 on record is dated 13 January 2026, one of 3 filings going back to 2024.
Where can I see all of James Joseph Martin's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James Joseph Martin and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial